The global medical imaging phantoms market size is estimated to reach USD 255.7 million by 2030, registering to grow at a CAGR of 5.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. Diagnostic radiology is widely adopted for precision diagnosis of brain injuries, cancer, and other diseases. In addition, computed tomography (CT) scan and magnetic resonance imaging (MRI) are widely used techniques. These phantoms help in enhancing the efficiency of these imaging devices by helping medical experts in detecting, interpreting, analyzing, and evaluating information required for treatments. Therefore, the increasing adoption of these devices for the diagnosis of severe diseases is expected to drive the market growth.
Effective reimbursement scenario of medical imaging and growing competition to provide advanced technologies are a few factors driving the adoption of the product. Moreover, the growing participation of key players in various radiology conferences is expected to drive the adoption of these devices and their respective phantoms. The increasing number of preclinical studies to understand the effectiveness of these phantoms for hybrid imaging devices is expected to expand the growth potential in the coming years.
The introduction of advanced materials and production techniques are some of the major factors expected to strengthen the applications of these phantoms for specific diseases. The introduction of advanced simulating phantoms is anticipated to provide deep insights on actual dynamics at a cellular level, thus enhancing the precision in diagnostics.
These devices have various associated advantages, which is a key factor driving the market growth. For instance, realistic medical imaging phantoms of organs and tissues are being developed using 3D technology to enhance the performance of medical imaging devices. This, in turn, is expected to drive the medical imaging phantom market growth over the forecast period.
Request a free sample copy or view report summary: Medical Imaging Phantom Market Report
CT (Computed Tomography) phantoms dominated the market and accounted for a share of 30.6% in 2024, driven by their essential function in facilitating accurate calibration and quality assurance of imaging systems.
Calibration & quality assurance led the market with a revenue share of 38.3% in 2024, fueled by their crucial role in maintaining accurate imaging and diagnostic reliability.
Hospitals & diagnostic imaging centers held the largest market share of 56.3% in 2024, aided by the rising prevalence of chronic diseases and the necessity for accurate diagnostic imaging.
North America medical imaging phantoms market dominated the global market with a revenue share of 36.4% in 2024.
Grand View Research has segmented the global medical imaging phantoms market based on product, application, end-use, and region:
Medical Imaging Phantoms Product Outlook (Revenue, USD Million, 2018 - 2030)
CT (Computed Tomography) Phantoms
MRI (Magnetic Resonance Imaging) Phantoms
Ultrasound Phantoms
X-ray Phantoms
Nuclear Medicine Phantoms
Others
Medical Imaging Phantoms Application Outlook (Revenue, USD Million, 2018 - 2030)
Calibration & Quality Assurance
Diagnostic Imaging
Research & Development
Training & Education
Therapeutic Applications
Medical Imaging Phantoms End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Diagnostic Imaging Centers
Medical Device Manufacturers
Others
Medical Imaging Phantoms Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Medical Imaging Phantoms Market
BARTEC Top Holding GmbH
Gold Standard Phantoms
IBA Worldwide
Kyoto Kagaku Co., Ltd.
Leeds Test Objects
Mirion Technologies, Inc.
PTW Freiburg GmbH
Pure Imaging Phantoms
RSD Radiology Support Devices
"The quality of research they have done for us has been excellent..."